Velaglucerase alfa in the treatment of Gaucher disease type 1

Por Burrow, Thomas A, Grabowski, Gregory A
Publicado em 2011

CNS, Lung, and Lymph Node involvement in Gaucher disease type 3 after 11 years of therapy: Clinical, Histopathologic, and Biochemical Findings

Por Burrow, Thomas A, Sun, Ying, Prada, Carlos E, Bailey, Laurie, Zhang, Wujuan, Brewer, Amanda, Wu, Steve W., Setchell, Kenneth D R, Witte, David, Cohen, Mitchell B, Grabowski, Gregory A
Publicado no Mol Genet Metab (2014)

Defects of B Cell Terminal Differentiation in Patients with Type-1 Kabuki Syndrome

Por Lindsley, Andrew W., Saal, Howard M., Burrow, Thomas A., Hopkin, Robert J., Shchelochkov, Oleg, Khandelwal, Pooja, Xie, Changchun, Bleesing, Jack, Filipovich, Lisa, Risma, Kimberly, Assa’ad, Amal H., Roehrs, Phillip A., Bernstein, Jonathan A.
Publicado no J Allergy Clin Immunol (2015)

De novo mutations in KIF1A cause progressive encephalopathy and brain atrophy

Por Esmaeeli Nieh, Sahar, Madou, Maura R Z, Sirajuddin, Minhajuddin, Fregeau, Brieana, McKnight, Dianalee, Lexa, Katrina, Strober, Jonathan, Spaeth, Christine, Hallinan, Barbara E, Smaoui, Nizar, Pappas, John G, Burrow, Thomas A, McDonald, Marie T, Latibashvili, Mariam, Leshinsky-Silver, Esther, Lev, Dorit, Blumkin, Luba, Vale, Ronald D, Barkovich, Anthony James, Sherr, Elliott H
Publicado no Ann Clin Transl Neurol (2015)